159 related articles for article (PubMed ID: 38287836)
21. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
[TBL] [Abstract][Full Text] [Related]
22. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
23. An integrated approach to understand fluid shear stress-driven and reactive oxygen species-mediated metastasis of colon adenocarcinoma through mRNA-miRNA-lncRNA-circRNA networks.
KrishnaPriya S; Omer S; Banerjee S; Karunagaran D; Suraishkumar GK
Mol Genet Genomics; 2022 Sep; 297(5):1353-1370. PubMed ID: 35831469
[TBL] [Abstract][Full Text] [Related]
24. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
Chen Y; Tian Z; Hou H; Gai W
BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Wang JY; Wang CL; Wang XM; Liu FJ
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
[TBL] [Abstract][Full Text] [Related]
26. Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma.
Tung CB; Li CY; Lin HY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948431
[TBL] [Abstract][Full Text] [Related]
27. Identification of key lncRNAs in the carcinogenesis and progression of colon adenocarcinoma by co-expression network analysis.
Jiang S; Tan B; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6490-6501. PubMed ID: 30430631
[TBL] [Abstract][Full Text] [Related]
28. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
29. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
Lin Y; Li Y; Chen Y; Zhang Z
Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
32. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.
Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J
Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153
[No Abstract] [Full Text] [Related]
33. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
34. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma.
Li Z; Tan H; Yu H; Deng Z; Zhou X; Wang M
J Cell Biochem; 2020 Mar; 121(3):2406-2415. PubMed ID: 31692079
[TBL] [Abstract][Full Text] [Related]
37. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.
Zeng JH; Liang L; He RQ; Tang RX; Cai XY; Chen JQ; Luo DZ; Chen G
Oncotarget; 2017 Mar; 8(10):16811-16828. PubMed ID: 28187432
[TBL] [Abstract][Full Text] [Related]
39. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
Front Immunol; 2022; 13():903758. PubMed ID: 36016939
[TBL] [Abstract][Full Text] [Related]
40. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
